ARS Pharmaceuticals, Inc. (SPRY) Total assets 2021–2025
ARS Pharmaceuticals, Inc. (SPRY) total assets at each fiscal year-end, per SEC filings.
$327.7MFY2025 · since FY2021: $61.4M → $327.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $327.7M | -6.7% |
| FY2024 | $351.2M | +50.6% |
| FY2023 | $233.2M | -17.1% |
| FY2022 | $281.4M | +358.0% |
| FY2021 | $61.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice